Feb 9, 2016 ... 9, 2016 /PRNewswire/ -- Athenex, Inc. announced today that Simon Pedder, PhD, has joined Athenex as Vice President of Corporate Strategy ...
View Simon Pedder's full profile. It's free! Your colleagues, classmates, and 500 million other professionals are on LinkedIn. View Simon's Full Profile ...
Jun 16, 2015 ... Seasoned drug and device industry executive Jim Caruso is taking over for Simon Pedder, who resigned his positions as Cellectar CEO, ...
Dr. Simon Pedder, Ph.D., served as the Founder and Chief Executive Officer of Chelsea Therapeutics International Ltd. from April 2004 until July 2012.
Simon Pedder, PhD. Chief Business and Strategy Officer, Proprietary Products. Simon has a long career in drug development including recent leadership roles ...
Dec 10, 2014 ... GOODRICH & ROASATI, Palo Alto, California, for Appellees Chelsea. Therapeutics International, Ltd., Simon Pedder, and William D.
Meet the Atlantic Research Group's Board of Directors.
May 27, 2016 ... Zak sued Chelsea — which is now owned by the Danish company H. Lundbeck A/S — its former president and CEO Simon Pedder, and former ...
Feb 11, 2014 ... ... eye toward taking the necessary steps to begin rebuilding shareholder value,” commented Dr. Simon Pedder, acting chief executive officer.